“Healthcare shouldn’t feel like a black box.” – Dr. Myra Ahmad

In this week’s episode, Steve sits down with Dr. Myra Ahmad (Founder & CEO of Mochi Health) to break down how telehealth is evolving—and why most healthcare systems still fail patients.

Dr. Myra explains how Mochi Health is building a marketplace model that connects providers, pharmacies, and patients into one seamless system—focused on long-term care, not just prescriptions. She shares why continuity with the same doctor matters, how transparent pricing is reshaping patient behavior, and why traditional healthcare often prioritizes systems over people.

The conversation dives into the GLP-1 explosion, the rise of peptides, and what’s actually coming next in weight loss and preventative medicine. They also unpack the role of AI in healthcare, where it works best (operations, workflows, efficiency) and where it still falls short (patient trust and real care). The episode closes with a grounded look at the “wild west” of online medications, how to think about safety and regulation, and what the next 3–5 years of telemedicine will really look like.

Takeaways

Most healthcare systems are built around operations—not patient experience.
Continuity of care (seeing the same provider long-term) leads to better outcomes.
GLP-1 drugs triggered massive demand—but they’re just the first wave.
Future treatments will expand into more conditions beyond weight loss.
Transparency in pricing is a major reason patients are shifting to telehealth.
AI is powerful for backend tasks—but not ready to replace doctors.
Patients still want human trust when it comes to medical decisions.
The peptide market is growing fast—but lacks consistent oversight.
Many online medications operate in a regulatory “gray zone.”
Telehealth’s growth will be driven by convenience, cost clarity, and access.

Chapters

00:00 Intro: Why healthcare systems fail patients

00:49 What Mochi Health actually does

02:10 Dr. Myra’s background & why she built Mochi

03:30 The gap in care delivery most people don’t see

05:10 Marketplace vs. traditional telehealth models

07:20 Why continuity with one doctor matters

09:15 GLP-1 drugs: from skepticism to global demand

12:40 What’s next in weight loss & new medications

15:30 Oral vs injectable treatments: what actually works

18:20 Peptides: hype, risks, and future potential

21:10 The “wild west” of online medications

24:00 AI in healthcare: where it works vs. where it fails

27:30 How Mochi uses AI to improve provider workflows

30:10 Pharmacy partnerships & quality control

33:40 Women’s health, HRT, and telehealth expansion

36:20 Pricing transparency vs traditional healthcare

39:10 The future of telemedicine (next 3–5 years)

42:00 What’s next for Mochi Health